ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 56 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 339.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $124,000 | -47.0% | 200,189 | +11.0% | 0.00% | 0.0% |
| Q3 2018 | $234,000 | -3.7% | 180,289 | -0.0% | 0.00% | 0.0% |
| Q2 2018 | $243,000 | +39.7% | 180,313 | +50.0% | 0.00% | 0.0% |
| Q1 2018 | $174,000 | +270.2% | 120,213 | +480.8% | 0.00% | – |
| Q4 2017 | $47,000 | +2250.0% | 20,697 | +3190.5% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 629 | +0.6% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 625 | +3.3% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 605 | +19.8% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 505 | -10.9% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 567 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 567 | -3.4% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 587 | +176.9% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 212 | +6.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 200 | +17.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |